BioSpyder Technologies
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5922 Farnsworth Ct Ste 102, Carlsbad, Ca...Phone Number
(760) 476-1800Website
www.biospyder.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BioSpyder Technologies
BioSpyder Technologies Inc. specializes in high-throughput gene expression profiling through its innovative product, TempO-Seq, which allows for the analysis of hundreds to thousands of genes simultaneously. The technology is designed to work with various sample types, including cell lysates and FFPE tissues, without the need for pre-amplification, making it suitable for both large-scale studies and limited samples. Their services are aimed at genomics labs looking for affordable and practical solutions for whole transcriptome profiling. Additionally, BioSpyder offers user-friendly bioinformatics tools to simplify data analysis for researchers.Explore more
BioSpyder Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioSpyder Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when BioSpyder Technologies launches new products
Funding: Get notified immidiatlly once BioSpyder Technologies has new funding data
Click to see if BioSpyder Technologies had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if BioSpyder Technologies has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on BioSpyder Technologies recently announced quarterly report
BioSpyder Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if BioSpyder Technologies is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at BioSpyder Technologies
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to BioSpyder Technologies
Compare insights from companies similar to BioSpyder Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioSpyder Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BioSpyder Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BioSpyder Technologies.
BioSpyder Technologies Tech Stack
A closer look at the technologies used by BioSpyder Technologies
Most Recent Scoops
Funding
Project
received an award of $1,241,285 on June 22, 2023 by HHS NIH with an award end date of May 31, 2025. This award will support efforts focused on optimizing and commercializing the TempO-LINC single-cell gene expression platform, enhancing its sensitivity, workflow, and multi-omic capabilities for large-scale, cost-effective analysis of thousands of samples..
Product Development, Analytics & Insights, Research & Development, Automation, Software, Medical Research, Clinical Operations, Healthcare Technology, Operations
Funding
Project
Product Launch
Product Launch, Clinical Systems
Product Launch
BioSpyder Technologies News & Media
BioSpyder Launches Barcode-Style COVID-19 Test
SAN DIEGO--(BUSINESS WIRE)-- #COVID19--BioSpyder launches TempO-SPan for high throughput, cost-effective COVID-19 testing. U.K. spin-out announces direct to the public testing service.HTG Molecular Provides Update on Patent Infringement Claims Against BioSpyder
TUCSON, Ariz., Aug. 14, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today provided an update regarding its patent infringement claims against BioSpyder Technologies, Inc (BioSpyder). On August 13, 2020, BioSpyder filed a lawsuit seeking a declaration that it does not infringe HTG’s U.S. Patent No. 8,741,564 (the ’564 patent). In several previous communications between the companies, HTG hadBioSpyder Files Action Against HTG Molecular Diagnostics in Federal Court
CARLSBAD, Calif.--(BUSINESS WIRE)--On Wednesday, August 12, 2020, BioSpyder Technologies, Inc. (“BioSpyder”) filed a civil action in the federal court for the Northern District of California, seeking a declaratory judgment that the BioSpyder TempO-Seq gene expression profiling assay does not infringe any valid claim in U.S. Patent No. 8,741,564 (“the ’564 patent”) for Quantitative Nuclease Protection Assay (QNPA) and Sequencing (QNPS) Improvements. HTG Molecular Diagnostics, Inc. (“HTG”) has reBioSpyder Awarded 5-Year EPA Contract With a Maximum Value of $25 Million to Perform High-Throughput Genetic Toxicology Screening
Faster, Cheaper, Better - TempO-Seq® Assay Establishes Itself as a Leading Gene Expression Profiling Tool
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding BioSpyder Technologies
Sign Up For FreeTo access detailed company insights
BioSpyder Technologies Inc. specializes in high-throughput gene expression profiling through its innovative product, TempO-Seq, which allows for the analysis of hundreds to thousands of genes simultaneously. The technology is designed to work with various sample types, including cell lysates and FFPE tissues, without the need for pre-amplification,... Read More
